Akero Therapeutics, Inc.
SEC Filing List
AKRO CIK: 0001744659
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 02/17/2026 | ||||
| SCHEDULE 13G/A | 02/17/2026 | ||||
| SCHEDULE 13G/A | ADVISER COMPLIANCE ASSOCIATES LLC /fa | 02/13/2026 | |||
| SCHEDULE 13G/A | 02/10/2026 | ||||
| 15-12G | Notice of termination of registration of... | Akero Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 12/19/2025 | |
| POSASR | Post-effective Amendment to an automatic... | Akero Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 12/09/2025 | |
| 4 | Statement of changes in beneficial owner... | Young Jonathan | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 12/09/2025 | |
| S-8 POS | Post-effective amendment to an S-8 regis... | Akero Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 12/09/2025 | |
| S-8 POS | Post-effective amendment to an S-8 regis... | Akero Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 12/09/2025 | |
| S-8 POS | Post-effective amendment to an S-8 regis... | Akero Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 12/09/2025 | |
| No record found. | |||||
| Load More | |||||
